NCT02609269Enrolling by invitation
Decipher Genomics Resource for Intelligent Discovery
Prospective Expression Analysis Using The Decipher Genomics Resource for Intelligent Discovery (GRID)® and Data Sharing Program
Source: ClinicalTrials.gov · Last updated 18 Aug 2026
Brief summary (registry, in English)
To prospectively evaluate the utility of genomic expression data and whole slide digital pathology image data as a tool to better characterize the tumors of individual patients, and to understand how genomic and histologic information from individual patients undergoing routine clinical testing can be used in population-level analysis to improve treatment and outcomes.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 1000000 (estimated)
- First submitted
- 16 Nov 2015
- Start date
- 1 Oct 2015
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- GenomeDx Biosciences Corp
- NCT number
- NCT02609269
What you commit to
- Study type: Observational
- Planned participants: 1000000
- From 1 Oct 2015 to the primary completion date, 31 Dec 2030
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Subjects that have had a Decipher clinical test
Sex: All · Does not accept healthy volunteers
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.